humanitarian

Opinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic ar…

Opinion/decision on a Paediatric investigation plan (PIP): Hetronifly, serplulimab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and…

Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewOpinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic ar…EMA What Is NewOpinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic ar…EMA What Is NewOpinion/decision on a Paediatric investigation plan (PIP): Sunosi, solriamfetol, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area…EMA What Is NewOpinion/decision on a Paediatric investigation plan (PIP): Sunosi, solriamfetol, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area…EMA What Is NewOpinion/decision on a Paediatric investigation plan (PIP): Galafold, migalastat hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, th…EMA What Is NewOpinion/decision on a Paediatric investigation plan (PIP): Galafold, migalastat hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, th…EMA What Is NewOpinion/decision on a Paediatric investigation plan (PIP): Besponsa, Inotuzumab ozogamicin, decision type: PM: decision on the application for modification of an agreed PIP, thera…EMA What Is NewOpinion/decision on a Paediatric investigation plan (PIP): Besponsa, Inotuzumab ozogamicin, decision type: PM: decision on the application for modification of an agreed PIP, thera…EMA What Is NewOpinion/decision on a Paediatric investigation plan (PIP): Venclyxto, venetoclax, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic are…EMA What Is NewOpinion/decision on a Paediatric investigation plan (PIP): Venclyxto, venetoclax, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic are…EMA What Is NewOpinion/decision on a Paediatric investigation plan (PIP): Hetronifly, serplulimab, decision type: W: decision granting a waiver in all age groups for all conditions or indication…EMA What Is NewOpinion/decision on a Paediatric investigation plan (PIP): Hetronifly, serplulimab, decision type: W: decision granting a waiver in all age groups for all conditions or indication…
INCIDENT EVOLUTION

4 recorded states

Signal first indexedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Headline updatedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →
QUALITY CONTROL

Report this signal

Reports are anonymous and retained privately for editorial review.